These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2292549

  • 1. Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients.
    Philpott-Howard JN, Barker KF, Wade JJ, Kaczmarski RS, Smedley JC, Mufti GJ.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():89-99. PubMed ID: 2292549
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
    Johnson PR, Liu Yin JA, Tooth JA.
    J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High dose intravenous ciprofloxacin in febrile neutropenic patients.
    Johnson PR, Yin JA, Tooth JA.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():101-7. PubMed ID: 2292537
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Peterson LR, Moody JA, Fasching CE, Gerding DN.
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
    Gibson J, Date L, Joshua DE, Young GA, Wilson A, Benn R, Benson W, Iland H, Vincent PC, Kronenberg H.
    Aust N Z J Med; 1989 Oct; 19(5):417-25. PubMed ID: 2686610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
    Yamamura D, Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1704-8. PubMed ID: 9257745
    [Abstract] [Full Text] [Related]

  • 19. Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.
    Smith L, Will AM, Williams RF, Stevens RF.
    J Infect; 1990 May; 20(3):201-6. PubMed ID: 2187928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.